Clinical Outcomes of Low-Dose Methotrexate Therapy as a Second-Line Drug for Intravenous Immunoglobulin-Resistant Kawasaki Disease

PURPOSE: Intravenous immunoglobulin (IVIG) is the standard treatment for Kawasaki disease (KD). However, there is still no standard treatment for IVIG-resistant KD. This study aimed to evaluate the efficacy of low-dose methotrexate (MTX) as a treatment for IVIG-resistant KD. MATERIALS AND METHODS: W...

Descripción completa

Detalles Bibliográficos
Autores principales: Jang, Hyejin, Kim, Kyu Yeun, Kim, Dong Soo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Yonsei University College of Medicine 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5725347/
https://www.ncbi.nlm.nih.gov/pubmed/29214785
http://dx.doi.org/10.3349/ymj.2018.59.1.113

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5725347/
https://www.ncbi.nlm.nih.gov/pubmed/29214785
http://dx.doi.org/10.3349/ymj.2018.59.1.113

Ejemplares similares